Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does myeloma genetic have an effect on stem cell mobilization?
Başcı S, Yiğenoğlu TN, Yaman S, Bozan E, Ulu BU, Bakırtaş M, Kılınç A, Özcan N, Bahsi T, Dal MS, Çakar MK, Altuntaş F. Başcı S, et al. Among authors: cakar mk. Transfus Apher Sci. 2021 Dec;60(6):103249. doi: 10.1016/j.transci.2021.103249. Epub 2021 Aug 17. Transfus Apher Sci. 2021. PMID: 34419357
Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
Dal MS, Tekgündüz E, Çakar MK, Kaya AH, Namdaroğu S, Batgi H, Bekdemir F, Uncu Ulu B, Yiğenoğlu TN, Kılınç A, İskender D, Uğur B, Koçubaba Ş, İskender G, Altuntaş F. Dal MS, et al. Among authors: cakar mk. Transfus Apher Sci. 2016 Aug;55(1):125-8. doi: 10.1016/j.transci.2016.05.001. Epub 2016 May 6. Transfus Apher Sci. 2016. PMID: 27184293
A 80-Year-Old Woman with B-Cell Prolymphocytic Leukemia.
Merdin A, Yıldız J, Dal Mehmet S, Çakar MK, Batgi H, Tekgündüz E, Onursever A, Altuntaş F. Merdin A, et al. Among authors: cakar mk. Hematol Rep. 2017 Mar 22;9(1):6995. doi: 10.4081/hr.2017.6995. eCollection 2017 Feb 23. Hematol Rep. 2017. PMID: 28435655 Free PMC article.
Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy.
Kaya AH, Tekgündüz E, Ilkkiliç K, Dal MS, Merdin A, Karakus A, Hacioglu SK, Bekdemir F, Çakar MK, Dogu MH, Ayyildiz MO, Korkmaz S, Altuntaş F; On the behalf of The Turkish Hematology Research and Edication Group (ThREG). Kaya AH, et al. Among authors: cakar mk. J Chemother. 2018 Feb;30(1):44-48. doi: 10.1080/1120009X.2017.1396017. Epub 2017 Nov 3. J Chemother. 2018. PMID: 29098953
The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma.
Çakar MK, Tekgündüz E, Dal MS, Merdin A, Başçı S, İskender D, Uğur B, Bekdemir F, Yıldız J, Ulu BU, Bakırtaş M, Yiğenoğlu TN, Batgi H, Kaya AH, İskender D, Altuntaş F. Çakar MK, et al. J Oncol Pharm Pract. 2020 Mar;26(2):273-278. doi: 10.1177/1078155219841110. Epub 2019 Apr 2. J Oncol Pharm Pract. 2020. PMID: 30940050
Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment.
Merdin A, İskender D, Ulu BU, Doğan M, Çakar MK, Dal MS, Altuntaş F. Merdin A, et al. Among authors: cakar mk. Medicine (Baltimore). 2019 Jul;98(30):e16482. doi: 10.1097/MD.0000000000016482. Medicine (Baltimore). 2019. PMID: 31348254 Free PMC article.
Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor.
Merdin A, Çakar MK, Dal MS, Mert D, Yıldız J, Başçı S, Bakırtaş M, Darçın T, Şahin D, Ulu BU, Yiğenoğlu TN, Batgi H, Tetik A, İskender D, Altuntaş F. Merdin A, et al. Among authors: cakar mk. J Oncol Pharm Pract. 2020 Jun;26(4):929-932. doi: 10.1177/1078155219891663. Epub 2019 Dec 10. J Oncol Pharm Pract. 2020. PMID: 31822199
31 results